𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Distribution and stability of [111In]bleomycin and its fractions in tumor-bearing mice

✍ Scribed by De-Yan Hou; Hans Hoch; Gerald S. Johnston; K.C. Tsou; Raymond J. Farkas; Elizabeth E. Miller

Book ID
116083913
Publisher
Elsevier Science
Year
1984
Weight
863 KB
Volume
11
Category
Article
ISSN
0047-0740

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A new 111in-bleomycin complex for tumor
A new 111in-bleomycin complex for tumor imaging: Preparation, stability, and distribution in glioma-bearing mice
✍ De-Yan Hou; Hans Hoch; Gerald S. Johnston; K. C. Tsou; Alfred E. Jones; Raymond πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 English βš– 895 KB

## Abstract A new ^111^In‐bleomycin complex (^111^In‐BLMC) is here reported. Its radiochemical purity was 99% by thin‐layer chromatography (TLC) (Rf 0.65) and in 5% agarose gel electrophoresis in 0.02 M NaHCO~3~ it migrated toward the anode. Autoradiographs of TLC and gel electrophoresis plates sho

Comparison of oncophilic radiopharmaceut
Comparison of oncophilic radiopharmaceuticals, *I-fibrinogen, 67Ga- citrate, 111In-bleomycin, and *I-bleomycin in tumor-bearing mice
✍ Gerald L. Denardo; Kenneth A. Krohn; Sally J. Denardo πŸ“‚ Article πŸ“… 1977 πŸ› John Wiley and Sons 🌐 English βš– 556 KB

The pharmacokinetics of E7Ga-citrate, "'In-bleomycin, \*I-bleomycin, and \*Ifibrinogen were compared in a murine KHJJ tumor model in order to assess their relative potential as agents for in vivo detection of cancer. Although all four agents have been reported to be clinically efficacious, in this t

A new tumor imaging agent-111In-bleomyci
A new tumor imaging agent-111In-bleomycin complex. Comparison with 67Ga-citrate and 57Co-Bleomycin in tumor-bearing animals
✍ De-Yan Hou; Hans Hoch; Gerald S. Johnston; K. C. Tsou; Alfred E. Jones; Elizabet πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 English βš– 778 KB

## Abstract We have found a new ^111^In‐bleomycin complex (BLMC), which has high affinity to tumor, does not bind to transferrin and is stable in vivo. Distribution in animals bearing glioma, hepatoma, or mammary adenocarcinoma at 48 hours showed: the ratios of tumor to blood, brain, heart, lung, l

Use of 111in-bleomycin for combining rad
Use of 111in-bleomycin for combining radiotherapy and chemotherapy on glioma-bearing mice
✍ De-Yan Hou; Hans Hoch; Gerald S. Johnston; K. C. Tsou; Raymond J. Farkas; Elizab πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 624 KB

Mice bearing transplanted glioma received 0.9% NaCl, 0.1 mg of BLM, or 200-250 pCi of "'In-BLM (0.1 mg BLM) daily for 5 days intraperitoneally. After therapy, tumor sizes were in the order NaCl > BLM > "'In-BLM. On the 11th day after the first injection, tumor size (m3) in the "'In-BLM group was 1,2